O-carboxymethyl chitosan in biomedicine: A review
Lingbin Chen,
No information about this author
Yandi Xie,
No information about this author
Xiaohang Chen
No information about this author
et al.
International Journal of Biological Macromolecules,
Journal Year:
2024,
Volume and Issue:
275, P. 133465 - 133465
Published: June 28, 2024
Language: Английский
Harnessing the immunomodulatory potential of chitosan and its derivatives for advanced biomedical applications
International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
unknown, P. 142055 - 142055
Published: March 1, 2025
Language: Английский
Nutraceuticals Targeting Cannabinoid Receptor 1 and Transient Receptor Potential Vanilloid 1 for Pain Relief: A Computational Screening Approach
Cureus,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 6, 2025
This
study
examined
the
binding
affinities
and
therapeutic
potential
of
natural
products
targeting
pain-related
receptors
using
molecular
docking
dynamics
(MD)
simulations.
Drug-like
properties
absorption,
distribution,
metabolism,
excretion,
toxicity
(ADMET)
analyses
were
also
conducted.
AutoDock
Vina
(The
Scripps
Research
Institute,
La
Jolla,
CA,
USA)
was
used
for
against
receptors,
including
transient
receptor
vanilloid
1
(TRPV1),
cyclooxygenase-2
(COX-2),
cannabinoid
(CB1),
mu-opioid
receptor,
nicotinic
acetylcholine
receptors.
Celecoxib
included
as
a
reference
drug
score
comparison.
Protein-ligand
complex
stability
assessed
via
100-nanosecond
(ns)
MD
simulations
GROMACS
(GROningen
MAchine
Chemical
Simulations;
University
Groningen,
Netherlands),
analyzing
root
mean
square
deviation
(RMSD)
radius
gyration
(Rg).
Drug-likeness
evaluated
by
Lipinski's
rule
five,
ADMET
analysis
performed
pharmacokinetics
profiling.
Ginsenoside
Rb1
exhibited
strong
affinity
TRPV1
(-9.5
kcal/mol)
(-9.0
suggesting
its
non-opioid
analgesic
candidate.
Cyanidin
3-O-rutinoside
demonstrated
high
to
(-9.35
kcal/mol),
COX-2
(-9.65
CB1
(-9.18
surpassing
celecoxib
(-7.22
in
binding.
confirmed
stability,
with
RMSD
(~3.0
Å)
Rg
nm)
values
lower
than
unbound
proteins.
Most
compounds
met
criteria,
indicating
good
oral
bioavailability.
revealed
favorable
absorption
distribution
low
toxicity.
cyanidin
exhibit
affinity,
pharmacokinetic
properties,
supporting
their
candidates.
Their
ability
modulate
pain
pathways
vitro
vivo
warrants
further
investigation.
Language: Английский
Techniques and applications in 3D bioprinting with chitosan bio-inks for drug delivery: A review
Zhaomin Yao,
No information about this author
Xin Feng,
No information about this author
Zheling Wang
No information about this author
et al.
International Journal of Biological Macromolecules,
Journal Year:
2024,
Volume and Issue:
278, P. 134752 - 134752
Published: Aug. 30, 2024
Language: Английский
Nano-enhanced immunity: A bibliometric analysis of nanoparticles in vaccine adjuvant research
Human Vaccines & Immunotherapeutics,
Journal Year:
2024,
Volume and Issue:
20(1)
Published: Nov. 14, 2024
This
study
analyzed
the
growth,
collaboration,
citation
trends,
and
emerging
topics
in
nanoparticle-based
vaccine
adjuvant
research
(NVAR)
from
1977
to
2023,
using
data
Scopus
database.
The
field
showed
a
steady
growth
rate
of
7.53%
per
year.
Leading
researchers
Jaafari,
M.R.
Alving,
C.R.
contributed
significantly
field,
with
24.22%
publications
38.92%
total
citations
coming
United
States.
International
collaboration
was
very
strong,
particularly
between
US,
UK,
Germany,
China,
France.
Key
include
nanoparticles,
immunotherapy,
COVID-19,
vaccines
focus
on
SARS-CoV-2
malaria.
Emerging
adjuvants,
mRNA,
neutralizing
antibodies.
emphasizes
importance
ongoing
interdisciplinary
efforts
advance
NVAR.
Language: Английский
Insulin-Loaded Chitosan–Cellulose-Derivative Hydrogels: In Vitro Permeation of Hormone through Strat-M® Membrane and Rheological and Textural Analysis
Polymers,
Journal Year:
2024,
Volume and Issue:
16(18), P. 2619 - 2619
Published: Sept. 16, 2024
This
work
is
part
of
the
current
research
trend
to
develop
a
hydrogel
carrier
insulin
promote
wound
healing.
Topically
applied
promotes
keratinocyte
proliferation
and
migration,
increases
collagen
synthesis,
reduces
inflammation
oxidative
stress,
exhibits
antimicrobial
activity.
The
aim
this
study
was
design
an
matrix
based
on
selected
cellulose
derivatives
(methylcellulose,
hydroxyethylcellulose,
hydroxypropylmethylcellulose)
chitosan.
Rheological
parameters
formulations
were
evaluated
using
rotational
rheometry
oscillation
test.
Textural
tests
performed.
In
vitro
pharmaceutical
availability
studies
carried
out
innovative
Strat-M®
membrane
imitate
skin
barrier.
It
found
that
formulation
chitosan
methylcellulose
showed
acceptable
balance
between
rheological
textural
ease
application.
API
released
from
in
prolonged
manner,
eliminating
need
apply
several
times
per
day.
developed
shows
potential
for
use
clinical
practice.
Language: Английский